138 related articles for article (PubMed ID: 3287289)
1. The interactions between drugs and the parasite surface.
Chappell LH
Parasitology; 1988; 96 Suppl():S167-93. PubMed ID: 3287289
[TBL] [Abstract][Full Text] [Related]
2. [Target points of antiparasitic drugs].
Boczoń K
Wiad Parazytol; 1988; 34(4-6):529-43. PubMed ID: 3071915
[No Abstract] [Full Text] [Related]
3. [Biochemistry of some parasitic helminths and protozoa and the mode of action of some antiparasitic drugs].
Metzger H
Z Parasitenkd; 1970; 34(4):271-95. PubMed ID: 4319926
[No Abstract] [Full Text] [Related]
4. The Role of Xenobiotic-Metabolizing Enzymes in Anthelmintic Deactivation and Resistance in Helminths.
Matoušková P; Vokřál I; Lamka J; Skálová L
Trends Parasitol; 2016 Jun; 32(6):481-491. PubMed ID: 26968642
[TBL] [Abstract][Full Text] [Related]
5. Incidence of antiprotozoal and antivermal antibiotics in fungi. IV. Fungi imperfecti, order Moniliales, collected in China.
Krizková L; Balan J; Balanová J; Nemec P
J Antibiot (Tokyo); 1974 Apr; 27(4):234-9. PubMed ID: 4212080
[No Abstract] [Full Text] [Related]
6. Drug resistance mechanisms in helminths: is it survival of the fittest?
James CE; Hudson AL; Davey MW
Trends Parasitol; 2009 Jul; 25(7):328-35. PubMed ID: 19541539
[TBL] [Abstract][Full Text] [Related]
7. The mevalonate pathway in parasitic protozoa and helminths.
Coppens I; Courtoy PJ
Exp Parasitol; 1996 Jan; 82(1):76-85. PubMed ID: 8617335
[No Abstract] [Full Text] [Related]
8. Tubulin as an antiprotozoal drug target.
Werbovetz KA
Mini Rev Med Chem; 2002 Dec; 2(6):519-29. PubMed ID: 12370037
[TBL] [Abstract][Full Text] [Related]
9. New mechanisms of drug resistance in parasitic protozoa.
Borst P; Ouellette M
Annu Rev Microbiol; 1995; 49():427-60. PubMed ID: 8561467
[TBL] [Abstract][Full Text] [Related]
10. Microtubules as target organelles for benzimidazole anthelmintic chemotherapy.
Gull K; Dawson PJ; Davis C; Byard EH
Biochem Soc Trans; 1987 Feb; 15(1):59-60. PubMed ID: 3556740
[No Abstract] [Full Text] [Related]
11. Drug transfer into target helminth parasites.
Alvarez LI; Mottier ML; Lanusse CE
Trends Parasitol; 2007 Mar; 23(3):97-104. PubMed ID: 17236810
[TBL] [Abstract][Full Text] [Related]
12. Studies of the mode of action of anthelmintic drugs: tools to investigate the biochemical peculiarities of helminths.
Vanden Bossche H
Ann Parasitol Hum Comp; 1990; 65 Suppl 1():99-102. PubMed ID: 2264693
[TBL] [Abstract][Full Text] [Related]
13. In situ potentiometric method to evaluate bacterial outer membrane-permeabilizing ability of drugs: example using antiprotozoal diamidines.
Ando M; Kamei R; Komagoe K; Inoue T; Yamada K; Katsu T
J Microbiol Methods; 2012 Dec; 91(3):497-500. PubMed ID: 23046554
[TBL] [Abstract][Full Text] [Related]
14. Xenobiotic metabolizing enzymes and metabolism of anthelminthics in helminths.
Cvilink V; Lamka J; Skálová L
Drug Metab Rev; 2009; 41(1):8-26. PubMed ID: 19514969
[TBL] [Abstract][Full Text] [Related]
15. Clinical pharmacology of ivermectin.
Bennett DG
J Am Vet Med Assoc; 1986 Jul; 189(1):100-4. PubMed ID: 3525478
[No Abstract] [Full Text] [Related]
16. [Helminth nervous system as a field for anthelmintic action].
Boczoń K
Wiad Parazytol; 1996; 42(4):373-9. PubMed ID: 9103048
[TBL] [Abstract][Full Text] [Related]
17. Benzimidazole resistance in helminths: From problem to diagnosis.
Furtado LFV; de Paiva Bello ACP; Rabelo ÉML
Acta Trop; 2016 Oct; 162():95-102. PubMed ID: 27338184
[TBL] [Abstract][Full Text] [Related]
18. Control of avermectin biosynthesis in Streptomyces avermitilis for the selective production of a useful component.
Ikeda H; Omura S
J Antibiot (Tokyo); 1995 Jul; 48(7):549-62. PubMed ID: 7649850
[No Abstract] [Full Text] [Related]
19. Mitochondrion of protozoan parasite emerges as potent therapeutic target: exciting drugs are on the horizon.
Sen N; Majumder HK
Curr Pharm Des; 2008; 14(9):839-46. PubMed ID: 18473833
[TBL] [Abstract][Full Text] [Related]
20. Parasite proteinases and amino acid metabolism: possibilities for chemotherapeutic exploitation.
Coombs GH; Mottram JC
Parasitology; 1997; 114 Suppl():S61-80. PubMed ID: 9309769
[No Abstract] [Full Text] [Related]
[Next] [New Search]
